No 10Y consistency score for revenue — its stored periods are half-year spaced, so quarter-over-same-quarter consistency is not computed.
Valuation vs own 10Y history: No P/S history yet
Annual revenue · last 11 fiscal years
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
Revenue growth
N/A
5Y CAGR
Gross margin
N/A
TTM
Price / op. cash flow
N/A
trailing two half-years
EV / EBITDA
9.9×
trailing two half-years
The latest delayed quote for British American Tobacco p.l.c. (BTI) stock was $53.13 as of Oct 6, 2026, 2:55 PM EDT, up 0.46% from the previous close.
Longer view (total return, dividends reinvested): past 12 months +9.3% · 3-year avg +29.4%/yr · 5-year avg +17.0%/yr
British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the United States, Europe, Latin America, Canada, the Asia-Pacific, the Middle East, Central Asia, Caucasus, and Africa.
Tobacco · London, GL
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · GBP
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2022-12-31 · GBP
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Next Earnings Date
Feb 11, 2027
128 days away
EPS Estimate
2.63
Revenue Est.
$18.58B
Last Quarter Results
EPS
$2.25
vs Estimate
$2.21
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1BTI | $114.59B | $53.13 | +0.46% | +9.34% | +16.96% | +5.30% | N/A |
| 2MO | $114.20B | $68.39 | +0.76% | +10.22% | +16.70% | +8.26% | vs BTI |
| 3MNST | $84.11B | $43.00 | -1.17% | +29.37% | +14.21% | +13.65% | vs BTI |
| 4BUD | $149.25B | $75.78 | +1.29% | +27.68% | +7.42% | -3.38% | vs BTI |
| 5MDLZ | $75.73B | $59.34 | +1.44% | -3.29% | +2.63% | +5.64% | vs BTI |
| 6TGT | $69.91B | $153.93 | +0.61% | +78.20% | -4.70% | +11.81% | vs BTI |
1.79
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
$16.43B
vs Estimate
$16.42B
Consensus Rating
Based on 6 analysts
Average Price Target
$70.43
+32.6% upside
Low
$63.00
Current
$53.13
High
$75.00
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | GBP 3.55 | GBP 3.60 | GBP 3.65 | 3 |
| FY 2027 | GBP 3.79 | GBP 3.87 | GBP 3.95 | 4 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | GBP 25.69B | GBP 26.06B | GBP 26.26B | 8 |
| FY 2027 | GBP 26.74B | GBP 27.02B | GBP 27.21B | 9 |
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
